These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8577053)

  • 21. Structural analysis of the mouse prosaposin (SGP-1) gene reveals the presence of an exon that is alternatively spliced in transcribed mRNAs.
    Zhao Q; Hay N; Morales CR
    Mol Reprod Dev; 1997 Sep; 48(1):1-8. PubMed ID: 9266755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mutation in the saposin C domain of the sphingolipid activator protein (Prosaposin) gene causes neurodegenerative disease in mice.
    Yoneshige A; Suzuki K; Suzuki K; Matsuda J
    J Neurosci Res; 2010 Aug; 88(10):2118-34. PubMed ID: 20175216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-neuronopathic Gaucher disease due to saposin C deficiency.
    Tylki-Szymańska A; Czartoryska B; Vanier MT; Poorthuis BJ; Groener JA; Ługowska A; Millat G; Vaccaro AM; Jurkiewicz E
    Clin Genet; 2007 Dec; 72(6):538-42. PubMed ID: 17919309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent advances in molecular genetics of GM2 gangliosidosis].
    Wakamatsu N
    Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synopsis: gangliosidoses.
    Schwab ME; Vassella F
    Neuropediatrics; 1984 Sep; 15 Suppl():107-9. PubMed ID: 6100793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of GM2 activator protein with glycosphingolipids.
    Hama Y; Li YT; Li SC
    J Biol Chem; 1997 Jan; 272(5):2828-33. PubMed ID: 9006924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Isolation and characteristics of hexosaminidase A and activator protein from human kidney].
    Aronovich EL; Akhunov VS; Krasnopol'skaia KD
    Biokhimiia; 1990 Jan; 55(1):43-51. PubMed ID: 2140519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations causing Gaucher disease.
    Horowitz M; Zimran A
    Hum Mutat; 1994; 3(1):1-11. PubMed ID: 8118460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted disruption of the mouse prosaposin gene affects the development of the prostate gland and other male reproductive organs.
    Morales CR; Zhao Q; El-Alfy M; Suzuki K
    J Androl; 2000; 21(6):765-75. PubMed ID: 11105903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sphingolipid activator proteins.
    Suzuki K
    Essays Biochem; 1995; 29():25-37. PubMed ID: 9189712
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
    Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.
    Bradová V; Smíd F; Ulrich-Bott B; Roggendorf W; Paton BC; Harzer K
    Hum Genet; 1993 Sep; 92(2):143-52. PubMed ID: 8370580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.
    Paton BC; Schmid B; Kustermann-Kuhn B; Poulos A; Harzer K
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):481-8. PubMed ID: 1637339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel sequence involved in lysosomal sorting of the sphingolipid activator protein prosaposin.
    Zhao Q; Morales CR
    J Biol Chem; 2000 Aug; 275(32):24829-39. PubMed ID: 10818106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activator protein for the enzymic hydrolysis of sphingolipids and their relationships to sphingolipidosis. Special reference to the catabolism of GM2 ganglioside].
    Hirabayashi Y; Li YT; Li SC
    Seikagaku; 1983; 55(1):1-13. PubMed ID: 6405000
    [No Abstract]   [Full Text] [Related]  

  • 36. The mouse gene encoding the GM2 activator protein (Gm2a): cDNA sequence, expression, and chromosome mapping.
    Yamanaka S; Johnson ON; Lyu MS; Kozak CA; Proia RL
    Genomics; 1994 Dec; 24(3):601-4. PubMed ID: 7713516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saposins: structure, function, distribution, and molecular genetics.
    Kishimoto Y; Hiraiwa M; O'Brien JS
    J Lipid Res; 1992 Sep; 33(9):1255-67. PubMed ID: 1402395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo.
    Klein A; Henseler M; Klein C; Suzuki K; Harzer K; Sandhoff K
    Biochem Biophys Res Commun; 1994 May; 200(3):1440-8. PubMed ID: 8185598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
    Inui K; Grebner EE; Jackson LG; Wenger DA
    Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency.
    Rafi MA; de Gala G; Zhang XL; Wenger DA
    Somat Cell Mol Genet; 1993 Jan; 19(1):1-7. PubMed ID: 8460394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.